Journey Medical Corp (DERM)
5.50
+0.30
(+5.77%)
USD |
NASDAQ |
Nov 22, 13:55
Journey Medical Enterprise Value: 105.95M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 105.95M |
| November 20, 2024 | 106.58M |
| November 19, 2024 | 109.08M |
| November 18, 2024 | 102.82M |
| November 15, 2024 | 105.12M |
| November 14, 2024 | 103.44M |
| November 13, 2024 | 104.28M |
| November 12, 2024 | 111.17M |
| November 11, 2024 | 113.89M |
| November 08, 2024 | 114.44M |
| November 07, 2024 | 115.69M |
| November 06, 2024 | 110.09M |
| November 05, 2024 | 106.77M |
| November 04, 2024 | 107.60M |
| November 01, 2024 | 125.22M |
| October 31, 2024 | 116.52M |
| October 30, 2024 | 116.00M |
| October 29, 2024 | 116.31M |
| October 28, 2024 | 121.70M |
| October 25, 2024 | 116.72M |
| October 24, 2024 | 109.67M |
| October 23, 2024 | 120.66M |
| October 22, 2024 | 124.81M |
| October 21, 2024 | 128.33M |
| October 18, 2024 | 124.18M |
| Date | Value |
|---|---|
| October 17, 2024 | 121.08M |
| October 16, 2024 | 127.50M |
| October 15, 2024 | 116.72M |
| October 14, 2024 | 118.38M |
| October 11, 2024 | 118.17M |
| October 10, 2024 | 121.70M |
| October 09, 2024 | 120.66M |
| October 08, 2024 | 123.77M |
| October 07, 2024 | 127.71M |
| October 04, 2024 | 132.68M |
| October 03, 2024 | 127.71M |
| October 02, 2024 | 127.29M |
| October 01, 2024 | 117.76M |
| September 30, 2024 | 114.44M |
| September 27, 2024 | 114.40M |
| September 26, 2024 | 109.21M |
| September 25, 2024 | 108.18M |
| September 24, 2024 | 103.62M |
| September 23, 2024 | 102.79M |
| September 20, 2024 | 100.51M |
| September 19, 2024 | 101.13M |
| September 18, 2024 | 101.96M |
| September 17, 2024 | 100.51M |
| September 16, 2024 | 108.38M |
| September 13, 2024 | 102.79M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
5.102M
Minimum
Dec 21 2022
149.47M
Maximum
Nov 12 2021
55.46M
Average
42.47M
Median
Enterprise Value Benchmarks
| Fortress Biotech Inc | 4.317M |
| Heron Therapeutics Inc | 264.81M |
| Eton Pharmaceuticals Inc | 261.60M |
| Elutia Inc | 148.97M |
| NovaBay Pharmaceuticals Inc | 2.798M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.39M |
| Revenue (Quarterly) | 14.63M |
| Total Expenses (Quarterly) | 17.52M |
| EPS Diluted (Quarterly) | -0.12 |
| Gross Profit Margin (Quarterly) | 63.87% |
| Profit Margin (Quarterly) | -16.34% |
| Earnings Yield | -17.09% |
| Normalized Earnings Yield | -17.99 |